Restarting Eliquis (Apixaban) After Colonoscopy
Eliquis (apixaban) should be restarted up to 48 hours after colonoscopy, depending on the bleeding risk from the procedure and the patient's thrombotic risk. 1
Risk Stratification
Procedure-Related Bleeding Risk
Low-risk procedures (bleeding risk <1%):
- Diagnostic colonoscopy with or without biopsies
- Resume Eliquis the same day once adequate hemostasis is achieved
High-risk procedures (bleeding risk >1%):
- Colonoscopy with polypectomy
- Endoscopic mucosal resection (EMR)
- Endoscopic submucosal dissection (ESD)
- Resume Eliquis 24-48 hours after the procedure
Patient Thrombotic Risk
High thrombotic risk:
- Mechanical mitral valve
- Prosthetic valve with prior thromboembolism
- Recent (<3 months) venous thromboembolism
- Atrial fibrillation with prior stroke or multiple risk factors
- Resume Eliquis earlier (24 hours post-procedure)
Low thrombotic risk:
- Non-valvular atrial fibrillation with lower CHADS₂ score
3 months after venous thromboembolism
- Can delay Eliquis resumption to 48 hours post-procedure
Specific Timing Recommendations
For diagnostic colonoscopy without intervention:
- Resume Eliquis the same day once adequate hemostasis is achieved 1
For colonoscopy with polypectomy or other high-risk intervention:
For large or complex polypectomies (polyps ≥20mm or piecemeal resection):
- Consider delaying Eliquis resumption for 48-72 hours 2
Important Considerations
The risk of post-polypectomy bleeding can be as high as 0.8-23% in anticoagulated patients compared to 0.07-1.7% in non-anticoagulated patients 2
Unlike warfarin, Eliquis reaches therapeutic anticoagulation levels within 2-4 hours after administration, so timing of resumption is critical 3
No bridging anticoagulation is required when restarting Eliquis 1, 2
The FDA label for Eliquis states that it "should be restarted after surgical or other procedures as soon as adequate hemostasis has been established" 3
A 2022 study showed that most patients achieve clinically insignificant levels of apixaban (≤30 ng/mL) within 48 hours of discontinuation 4
Practical Algorithm
Assess procedure outcome:
- Was there complete hemostasis?
- Were there any complications during the procedure?
- Size and number of polyps removed?
Evaluate patient's thrombotic risk:
- Review indication for anticoagulation
- Consider comorbidities and risk factors
Determine timing:
- Uncomplicated diagnostic procedure → Resume same day
- Standard polypectomy with low thrombotic risk → Resume at 48 hours
- Standard polypectomy with high thrombotic risk → Resume at 24 hours
- Complex polypectomy → Consider delaying to 48-72 hours
Monitor for complications:
- Educate patient about signs of bleeding
- Schedule appropriate follow-up
By following this evidence-based approach to restarting Eliquis after colonoscopy, you can balance the risks of thromboembolism against the risks of post-procedural bleeding.